Your browser doesn't support javascript.
loading
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy.
Yanagisawa, Takafumi; Hata, Kenichi; Narita, Shintaro; Hatakeyama, Shingo; Mori, Keiichiro; Yata, Yuji; Sano, Takayuki; Otsuka, Takashi; Hara, Shuhei; Miyajima, Keiichiro; Enei, Yuki; Fukuokaya, Wataru; Nakazono, Minoru; Matsukawa, Akihiro; Miki, Jun; Habuchi, Tomonori; Ohyama, Chikara; Shariat, Shahrokh F; Kimura, Takahiro.
Affiliation
  • Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Hata K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Narita S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Hatakeyama S; Department of Urology, Atsugi City Hospital, Kanagawa, Japan.
  • Mori K; Department of Urology, Akita University School of Medicine, Akita, Japan.
  • Yata Y; Department of Urology, Division of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Aomori, Japan.
  • Sano T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Otsuka T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Hara S; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Miyajima K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Enei Y; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Nakazono M; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Matsukawa A; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Miki J; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Habuchi T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Ohyama C; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
  • Shariat SF; Department of Urology, Akita University School of Medicine, Akita, Japan.
  • Kimura T; Department of Urology, Division of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, Aomori, Japan.
Prostate ; 83(6): 563-571, 2023 05.
Article in En | MEDLINE | ID: mdl-36661102
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Prostate Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostatic Neoplasms, Castration-Resistant Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Prostate Year: 2023 Document type: Article